FDA Consumer Health Information - FDA's MedWatch Safety Alerts: May 2011

SILVER SPRING, Md., June 28, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has recently issued safety alerts about a number of products, including:

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

  • birth control pills that may increase the risk of blood clots
  • Avandia and other diabetes medicines that carry new restrictions
  • dietary supplements packaged to look like antibiotics
  • a recalled blood thinner

These and other alerts were prompted by reports FDA received from health care professionals and the public through the agency's MedWatch Adverse Event Reporting Program.

Learn more about these safety alerts and what to do if you've used one of the products described here.

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm258350.htm

Sign up for e-mail notices of new FDA Consumer Updates at

https://service.govdelivery.com/service/subscribe.html?code=USFDA_9


View the FDA Consumer Update RSS feed at http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: [email protected].

Media Contact: Jason Brodsky, 301-796-8234, [email protected]

SOURCE U.S. Food and Drug Administration

Suggested Articles

With a pack of drugmakers angling for COVID-19 vaccine approvals in the coming months, the task of global distribution is more important than ever. Wi

"We have a chance to improve our reputation if we deliver on our purpose to find solutions responsibly," GSK CEO Emma Walmsley said.

The FDA knocked India's Panacea Biotec for failing to adequately identify isolated microbes in its aseptic manufacturing facility.